Skip to main content
NEW! The Investment Opportunity Report
The Investment Opportunity Report
Download Now

Looking For Our European Funds?

Click Here
About How To Invest
Ark Logo

Select Your Region

CONTINUE TO U.S. SITE VISIT EUROPEAN SITE
Mentioned Companies: GTLB, SHOP, PLTR, ABSI, RXRX

AI Agents And The Intelligent Software Economy

Apr 23, 2025
17 min read

As we recently discussed in our Introduction to the ARK Next Generation Internet ETF (ARKW) blog, artificial intelligence (AI) is rapidly transforming industries—from reshaping enterprise software to revolutionizing customer service and beyond. Building on those foundational insights, this article dives deeper into the revolutionary implications of AI agents, examining their architecture, economic implications, and inevitable disruption of traditional software models.

The software industry stands on the threshold of its most significant transformation since the birth of cloud computing. As highlighted in ARK’s Big Ideas 2025, AI agents—intelligent systems capable of autonomous reasoning, planning, and execution—are poised to reshape nearly every facet of business and consumer life, driving what may become the most profound computing shift since the internet itself.


Source: ARK Investment Management LLC, 2025.1 For informational purposes only and should not be considered investment advice or a recommendation to buy, sell, or hold any particular security.


The Evolution of Software: From Static to Autonomous

Historically, software has been relatively deterministic and passive—tools waiting for direct human commands. AI agents fundamentally reverse that relationship. By leveraging advanced natural language understanding and generative reasoning, the new systems become proactive, autonomous problem-solvers—not passive executors.


Source: ARK Investment Management LLC, 2025.2 For informational purposes only and should not be considered investment advice or a recommendation to buy, sell, or hold any particular security.


Whereas traditional software is built around rule-based logic and explicit programming, AI agents leverage large language models (LLMs), real-time reasoning, and autonomous learning capabilities to:

  • Identify user intent intuitively via natural language understanding.
  • Independently generate and execute multi-step action plans without human oversight.
  • Continuously improve and adapt by incorporating reinforcement learning and external feedback loops.


Economic Impact and Productivity Gains

Our research forecasts that AI agents could deliver unprecedented productivity increases, fundamentally altering enterprise software economics. By 2030, enterprise spending on AI-native software could expand dramatically as firms increasingly rely on autonomous systems to streamline operations. Innovative platforms offered by companies like Palantir embed agent-like functionality into enterprise workflows, signaling the early stages of this economic shift. Positioned as the operating system for government and enterprise AI applications, Palantir’s artificial intelligence platform (AIP) enables enterprises to build custom AI-driven software solutions instead of using the one-size-fits-none software products currently available. By providing a unified platform—customized to the needs of each enterprise—for data integration, automation, and decision making, Palantir helps organizations leverage AI to enhance operational efficiency and strategic planning.

Palantir’s offerings potentially represent a structural shift in economics on the order of that seen when personal computing replaced mainframes or when cloud computing overtook traditional data centers. We believe that businesses adopting AI-agent technologies early could experience substantial competitive advantages through enhanced efficiency, lower labor costs, and superior decision-making processes.


The Consumer AI Revolution

Our research suggests that consumers are increasingly likely to move away from traditional apps toward AI agents that fulfill needs proactively. Instead of navigating separate apps manually, consumers should come to rely on personalized digital assistants that anticipate intent, manage complex tasks (from travel planning to financial management), and integrate into daily routines seamlessly. Some digital wallets are bringing this process to life today. Integrated with Perplexity.ai, Shop Pay, offered by Shopify (SHOP), addresses search by encouraging users to explore product recommendations and complete purchases. Similarly, Klarna’s OpenAI-powered shopping assistant combines search and aggregation with product suggestions based on user preferences, as shown below.


Source: ARK Investment Management LLC, 2025.3 For informational purposes only and should not be considered investment advice or a recommendation to buy, sell, or hold any particular security.


In our view, companies that fail to integrate agentic AI will be unable to meet rising expectations for convenience and personalization, ultimately losing relevance.


Scientific Acceleration and Catalyzing R&D Breakthroughs

AI agents are also uniquely capable of managing complex, iterative scientific and engineering processes. Our analyses show that AI-driven research workflows should shorten research and development (R&D) timelines, reduce costs, and accelerate discovery across biotech, pharmaceuticals, and materials science. Specifically:

  • Drug Discovery: AI agents simulate millions of molecular interactions autonomously, significantly accelerating new therapies. Companies like Recursion Pharmaceuticals (RXRX) and Absci (ABSI) are at the forefront of this transformation, utilizing AI to automate and accelerate the identification and development of new drugs. Interestingly, “Big Pharma” companies are not the innovators in this field; they are following innovation through partnerships. Players like Recursion should be poised to hold dominant positions in the space.
    • Recursion has reduced the cost and time of drug development by leveraging AI to run millions of experiments simultaneously, an approach that speeds up the discovery process and reduces the risk of failure by allowing researchers to focus on the most promising candidates early on. Recursion’s recent merger with Exscientia, a leader in AI-driven chemistry, further enhances its ability to bring first-in-class and best-in-class drugs to market more quickly and less expensively.
    • Another great example of AI-drug discovery integration, Absci’s "zero-shot"4 approach to antibody development exemplifies the power of AI in drug discovery. By predicting the best design for a new antibody without the need for extensive trial and error, Absci can shorten the drug development timeline and reduce costs significantly, improving patient outcomes by bringing effective treatments to market more quickly while benefiting investors through faster returns on investment. As it has improved its efficiencies, Absci also has achieved increased efficacy relative to incumbents. In their seminal paper on "zero-shot," Absci identified five antibody candidates that demonstrated superior performance compared to the current market leader in antibody-based drugs targeting human epidermal growth factor receptor (HER2) in breast cancer.
  • Software Development: AI reduces timelines dramatically by identifying bugs and writing and testing code autonomously. Companies like GitLab (GTLB) are advancing this frontier by creating AI-powered development environments that boost coder productivity and automate low-level software engineering tasks. GitLab is a DevOps platform that provides a comprehensive suite of tools for software development, deployment, and collaboration, allowing development teams to manage the entire software development lifecycle in one centralized location. 

Industries historically limited by labor-intensive R&D could witness rapid leaps in innovation as AI agents autonomously explore solutions at unprecedented scale and speed.


3 Phases of AI Agents: Siloed → Platform → Universal Intelligence

The journey toward fully autonomous AI is incremental, yet profound. At ARK, we have identified three distinct phases:

  1. Siloed, Single-Purpose Agents: Specialized AI systems for isolated tasks.
  2. Platform-Level Agents: AI integrated into platforms, handling complex workflows across multiple domains autonomously.
  3. Universal Agents: General-purpose autonomous AI systems with human-like adaptability.

Today, the world is progressing swiftly into the platform-level agent phase, with major implications for industry structure and human employment. Platform-level agents increasingly will manage integrated business processes—such as complex enterprise resource planning, logistics, and customer management—requiring minimal human intervention.


Monetization and the Creation of New Marketplaces

While the market currently is experimenting with various pricing strategies for AI capability, we anticipate significant economic value creation from AI agents, arising primarily from three monetization strategies:

  1. Agent-as-a-Service (AaaS): Subscription models for sophisticated AI-driven workflows.
  2. AI Marketplaces and APIs (Application Programming Interfaces): Platforms that allow businesses and consumers to exchange AI-driven capabilities and tasks, charging for those tools based on consumption.
  3. Autonomous Commerce: AI agents performing transactions independently, boosting e-commerce growth and reshaping market dynamics.

It is likely that companies will mix and match those monetization methods in search of an optimal strategy. For example, Replit, which offers an AI coding agent as part of its cloud-native software development environment, provides a specific amount of AI usage credits as part of a base subscription but will charge on a consumption basis for overage. The pricing method gives businesses the stability baseline expenses they are looking for while aligning interests on value delivered for heavy users.


Source: ARK Investment Management LLC, 2025.5 This ARK analysis draws on a range of external data sources, including Hartig 1998, Dediu 2017, and Sidoti et al. 2024, as of December 31, 2024, which may be provided upon request.6 For informational purposes only and should not be considered investment advice or a recommendation to buy, sell, or hold any particular security. Past performance is not indicative of future results. 


As shown in the chart above, companies like OpenAI at the forefront of deploying those monetization strategies are positioning themselves within emerging, high-value marketplaces enabled by AI agents. The viral success of OpenAI’s ChatGPT created a powerful data flywheel that continues to refine and improve its underlying models. Simultaneously, paid tiers for “prosumers” and business users have spurred strong demand for ChatGPT as a commercial offering tailor-made for employees eager to integrate generative AI into their workflows. Furthermore, API access to OpenAI’s products is creating an ecosystem of AI applications that leverage OpenAI models and agentic frameworks, cultivating a community of developers who are expanding the potential use cases for ChatGPT.

To see ARK’s full investment thesis on OpenAI please visit our OpenAI Investment Thesis.


Reshaping Our Future

As articulated in ARK’s Investment Opportunity Report, AI agents represent a revolutionary computing paradigm shift that redefines software, consumer behavior, and business productivity. Far beyond incremental change, this structural evolution of software into autonomous intelligent systems will touch every industry and create entirely new economic ecosystems.

ARK’s active strategies like the ARK Next Generation Internet ETF (ARKW), the ARK Genomic Revolution ETF (ARKG), and the ARK Venture Fund (ARKVX) are designed to capture these transformative shifts as AI agents reshape software, productivity, and value creation across industries. The companies and sectors prepared to integrate these powerful agents today will lead tomorrow’s economy.



Important Information

Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ARK Fund before investing. This and other information are contained in the ARK ETFs’ prospectuses and summary prospectuses, which may be obtained by visiting www.ark-funds.com. The prospectus and summary prospectus should be read carefully before investing.

An investment in an ARK Fund is subject to risks and you can lose money on your investment in an ARK Fund. There can be no assurance that the ARK Funds will achieve their investment objectives. The ARK Funds’ portfolios are more volatile than broad market averages. The ARK Funds also have specific risks, which are described below. More detailed information regarding these risks can be found in the ARK Funds’ prospectuses.

The principal risks of investing in the ARK Funds include:

Disruptive Innovation Risk. Companies that ARK believes are capitalizing on disruptive innovation and developing technologies to displace older technologies or create new markets may not in fact do so. Companies that initially develop a novel technology may not be able to capitalize on the technology. Companies that develop disruptive technologies may face political or legal attacks from competitors, industry groups or local and national governments. These companies may also be exposed to risks applicable to sectors other than the disruptive innovation theme for which they are chosen, and the securities issued by these companies may underperform the securities of other companies that are primarily focused on a particular theme.

Equity Securities Risk. The value of the equity securities the ARK Funds hold may fall due to general market and economic conditions. Foreign Securities Risk. Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities. Health Care Sector Risk. The health care sector may be affected by government regulations and government health care programs. Consumer Discretionary Risk. Companies in this sector may be adversely impacted by changes in domestic/international economies, exchange/interest rates, social trends and consumer preferences. Industrials Sector Risk. Companies in the industrials sector may be adversely affected by changes in government regulation, world events, economic conditions, environmental damages, product liability claims and exchange rates. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins.

Additional risks of investing in ARK ETFs include market, management and non-diversification risks, as well as fluctuations in market value NAV. ETF shares may only be redeemed directly with the ETF at NAV by Authorized Participants, in very large creation units. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

To view the top ten holdings for ARKW click here.

To view the top ten holdings for ARKG click here.

To view the top ten holdings for ARKVX click here.

ARK Investment Management LLC is the investment adviser to the ARK Funds.

Foreside Fund Services, LLC, distributor.

ARK’s statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain of the statements contained may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements.

Explore ARK Funds

Featured Funds:

ARKVX Icon

ARK Venture Fund

ARKW Icon

ARK Next Generation Internet ETF

ARKG Icon

ARK Genomic Revolution ETF

See All

Ready to Invest?

We believe all investors should have access to venture capital, cutting-edge research, impactful education, and a phenomenal user experience. Self-directed investors can download the SoFi App and get started today. Advisors can access ARKVX through Schwab, Fidelity, Pershing, and more!

Invest Now Here

ARK Trade Notifications

ARK offers fully transparent Exchange Traded Funds (“ETFs”) and provides investors with trade information for all actively managed ETFs.

ARK Invest logo
You Are Entering ark-funds.com

Please read this page before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which the funds are authorized for sale. By proceeding, you are confirming you understand that ARK Investment Management LLC or its affiliates (collectively, “ARK”), makes no representation that the content of the website is appropriate for use in all locations, or that the transactions, securities, products, instruments or services discussed at this website are available or appropriate for sale or use in all jurisdictions or countries, or by all investors or counterparties.


This section of the website is operated by ARK, and is only directed at U.S. investors or those otherwise authorized to conduct investment business in the U.S. Persons resident in territories other than the United States should not access this website.


It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction. Certain of the funds and advisory products and services referenced on this website may be managed or offered/provided by affiliates of ARK. Additionally, certain of the funds described in the following pages may be marketed in certain jurisdictions only. Any entity forwarding the material or information contained on this website, which is produced by ARK in the United States, to other parties takes full responsibility for ensuring compliance with applicable securities laws in connection with its distribution.


This website only includes information on those funds that are registered for sale in the United States.


By accessing this website, you are confirming that you agree to the Terms and Conditions of this website and that you are resident in the United States or those otherwise authorized to conduct investment business in the U.S.


The contents of this website have been prepared for informational purposes only without regard to the investment objectives, financial situation, or means of any particular person or entity, and ARK is not soliciting any action based upon them. No information included on this website is to be construed as investment advice or as a recommendation or a representation about the suitability or appropriateness of any fund; or an offer to buy or sell, or the solicitation of an offer to buy or sell, any security, financial product, or instrument; or to participate in any particular trading strategy. ARK recommends that you seek independent financial and tax advice before making any investment decisions. Investment in any of the funds described in this website should only be made on the basis of the terms and conditions of the most recent applicable offering documents (including any relevant supplements).


All material has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. Some of the content on this website may contain certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. From time to time, ARK may also make additional features available to users on this website on such terms and conditions as may be set forth in a modification to this Agreement or otherwise on the ARK website.


The ARK ETF Trust Thematic Actively Managed ETF’s are distributed by Foreside Fund Services, LLC (“Foreside“), which is not affiliated with ARK Investment Management LLC. Check the background of Foreside on FINRA’s BrokerCheck.


You should carefully consider the investment objective, risks, charges and expenses of a Fund before investing. A Fund’s prospectus and summary prospectus contain this and other important information about a Fund, which can be obtained by clicking the corresponding link or dialing the indicated phone number herein. Please read the appropriate prospectus carefully before investing.


GENERAL RISK FACTORS


You should be aware that past performance is not a reliable indicator of future performance. Please note that the price of units or shares and the income from them can fall as well as rise and you may not get back the amount originally invested. Income receivable may vary from the amount of income projected at the time of making the investment.


Exchange rate fluctuations may affect the value of an investment and any income derived from it.


If you exercise any right to redeem, you may not get back the amount initially invested if the unit or share price has fallen since you invested. Deductions for charges and expenses, particularly the initial charge (if any), are not made uniformly throughout the life of the investment, so if you redeem out of the investment during the early years, you may not get back the amount invested.


There can be no guarantee that the tax position or proposed tax position prevailing at the time of an investment will not change. Dividends and capital gains on securities issued in the relevant funds may be subject to withholding taxes imposed by the countries in which each particular fund invests.


The offering documents for the investment funds contain important information summarizing the relevant risk factors pertaining to the investment or relevant funds. Please note, however, that no summary of risk factors is exhaustive, and there may be other risks that could affect your investment. For your own benefit and protection you should read the most recent offering documents (including any relevant supplements) carefully before investing. If you do not understand any point please ask for further information.


The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject any of the funds described herein, ARK (including its affiliates) or any of their products or services to any registration, licensing or other authorization requirement within such jurisdiction or country. Nothing on this website shall be considered a solicitation to buy or sell a security, product or service (including advisory service) to any person.


HYPERLINKS


ARK does not recommend or endorse and accepts no responsibility for the content of any website not operated by ARK which you may visit by following a link from this website. You acknowledge and agree that neither ARK nor any of its affiliates is responsible for the availability of such third-party websites or resources, does not endorse, approve, investigate or verify, and is not responsible or liable for any content, advertising, products, or other materials on or available from such websites or resources. You further agree that neither ARK nor any of its affiliates shall be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such content, products or services available on such external websites or resources. These links are provided as a convenience and solely for informational purposes. ARK is not making any recommendation to invest in, purchase, or sell any securities or other products or services offered on the linked websites, nor has ARK sought to verify or confirm the information contained in the linked websites. Accordingly, ARK disclaims any responsibility for the linked websites.


No other website, without the prior written permission of ARK, is authorized to link to any part of this website.


COOKIES


ARK uses cookies for collecting user information from certain pages of this website. A cookie is a file that is stored on the hard disk of a computer by the web browser on a computer. It contains information sent by the website that a user has visited. A cookie identifies users and can store information about them and their use of a website. ARK uses cookies to keep track of user activity, which allows ARK to identify which areas of the website are more interesting to the users so that improvements can be made to this website.


ARK expressly reserves the right to monitor any use of this website.


I confirm that I have read and accept the Terms and Conditions of using this website and that I am based in the United States or those otherwise authorized to conduct investment business in the United States.